Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/94369
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: The optimal use of PEG-Asparaginase in relapsed ALL-Lessons from the ALLR3 clinical trial
Author: Masurekar, A.
Fong, C.
Hussein, A.
Revesz, T.
Hoogerbrugge, P.
Love, S.
Ciria, C.
Parker, C.
Krishnan, S.
Saha, V.
Citation: Blood Cancer Journal, 2014; 4(4):e203-1-e203-3
Publisher: Nature
Issue Date: 2014
ISSN: 2044-5385
2044-5385
Statement of
Responsibility: 
A Masurekar, C Fong, A Hussain, T Revesz, PM Hoogerbrugge, S Love, C Ciria, C Parker, S Krishnan, and V Saha
Keywords: Humans
Polyethylene Glycols
Asparaginase
Adolescent
Child
Female
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Description: letter to the editor
Rights: This work is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
DOI: 10.1038/bcj.2014.26
Published version: http://dx.doi.org/10.1038/bcj.2014.26
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_94369.pdfPublished version440.87 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.